COMMUNIQUÉS West-GlobeNewswire

TESARO Announces Participation at Two Investor Conferences

01/03/2018 - 22:15

WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]

Humanigen CEO to Present at Inaugural LD Micro Virtual Conference

01/03/2018 - 22:15

BRISBANE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and [...]

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

01/03/2018 - 22:10

BURLINGAME, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard

01/03/2018 - 22:05

KENNETT SQUARE, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it received written [...]

CytomX to Present at Upcoming Investor Conferences

01/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today [...]

ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2017 Results

01/03/2018 - 22:05

SAN CLEMENTE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/03/2018 - 22:05

BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Diversicare Announces 2017 Fourth Quarter Results

01/03/2018 - 22:05

BRENTWOOD, Tenn., March 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ), a premier provider of long-term care services, today announced its results for the fourth quarter ended [...]

OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

01/03/2018 - 22:05

MIAMI, March 01, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) reports business highlights and financial results for the three months ended December 31, 2017. Business Highlights RAYALDEE total prescriptions [...]

Cidara Announces Appointment of Chrysa Mineo as Independent Director

01/03/2018 - 22:05

SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of Chrysa [...]

Quotient Limited to Participate in the Cowen 38th Annual Global Health Care Conference

01/03/2018 - 22:05

JERSEY, Channel Islands, March 01, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]

Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

01/03/2018 - 22:05

MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (NASDAQ: VSAR ), an endocrine-focused biopharmaceutical company, today announced financial results for the fourth quarter and full year ended [...]

Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update

01/03/2018 - 22:01

TYMLOS ™ sales show accelerating market share growth, capturing approximately 32% of osteoporosis patients new to anabolic therapy Abaloparatide patch program advances with FDA alignment on regulatory pathway and [...]

Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 22:01

Company Expects to Submit Vitaros End of Review Meeting Request This Month Vitaros End-of-Review Meeting Expected to Occur in April 2018 Company Expects Cash Runway Through 2018 Conference Call / Webcast Today, March 1 [...]

Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 22:01

BERKELEY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today reported financial results for the year ended December 31, 2017. Net loss for the fourth quarter and year ended December 31 [...]

Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results and Recent Corporate Developments

01/03/2018 - 22:01

-- Fourth quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $57.3 million -- -- Cash and investment balance of $1.1 billion as of December 31, 2017 -- CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- [...]

Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer

01/03/2018 - 22:01

WATERTOWN, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results

01/03/2018 - 22:01

HOLLISTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, [...]

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs

01/03/2018 - 22:01

AMES, Iowa, March 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported consolidated financial results for the fourth quarter and year ended 2017, as well as progress in its clinical [...]